Pseudoprogression of Brain Tumors

Overview

Journal J Magn Reson Imaging

Date 2018 May 8

PMID 29734497

Citations 128

Authors

Stefanie C Thust

Martin J van den Bent

Marion Smits

Affiliations

Soon will be listed here.

Abstract

Level Of Evidence: 3 Technical Efficacy: Stage 2 J. Magn. Reson. Imaging 2018.

Citing Articles

Response Assessment in Long-Term Glioblastoma Survivors Using a Multiparametric MRI-Based Prediction Model.

de Godoy L, Rajan A, Banihashemi A, Patel T, Desai A, Bagley S Brain Sci. 2025; 15(2).

PMID: 40002479 PMC: 11852837. DOI: 10.3390/brainsci15020146.

Cancer brain metastasis: molecular mechanisms and therapeutic strategies.

Lu Y, Huang Y, Zhu C, Li Z, Zhang B, Sheng H Mol Biomed. 2025; 6(1):12.

PMID: 39998776 PMC: 11861501. DOI: 10.1186/s43556-025-00251-0.

Case report: Pseudoprogression mimicking neoplastic recurrence three months after completion of proton beam therapy for an IDH-mutant astrocytoma CNS WHO grade 3.

Heggebo L, Borgen I, Blakstad H, Saxhaug C, Ronning P, Niehusmann P Front Oncol. 2025; 15:1397912.

PMID: 39949738 PMC: 11821596. DOI: 10.3389/fonc.2025.1397912.

Modernizing Neuro-Oncology: The Impact of Imaging, Liquid Biopsies, and AI on Diagnosis and Treatment.

Rafanan J, Ghani N, Kazemeini S, Nadeem-Tariq A, Shih R, Vida T Int J Mol Sci. 2025; 26(3).

PMID: 39940686 PMC: 11817476. DOI: 10.3390/ijms26030917.

Advances in Glioblastoma Diagnosis: Integrating Genetics, Noninvasive Sampling, and Advanced Imaging.

Gough R, Treffy R, Krucoff M, Desai R Cancers (Basel). 2025; 17(1.

PMID: 39796751 PMC: 11720166. DOI: 10.3390/cancers17010124.

References

Mullins M, Barest G, Schaefer P, Hochberg F, Gonzalez R, Lev M . Radiation necrosis versus glioma recurrence: conventional MR imaging clues to diagnosis. AJNR Am J Neuroradiol. 2005; 26(8):1967-72. PMC: 8148818. View

Lacerda S, Law M . Magnetic resonance perfusion and permeability imaging in brain tumors. Neuroimaging Clin N Am. 2009; 19(4):527-57. DOI: 10.1016/j.nic.2009.08.007. View

Song Y, Choi S, Park C, Yi K, Lee W, Yun T . True progression versus pseudoprogression in the treatment of glioblastomas: a comparison study of normalized cerebral blood volume and apparent diffusion coefficient by histogram analysis. Korean J Radiol. 2013; 14(4):662-72. PMC: 3725362. DOI: 10.3348/kjr.2013.14.4.662. View

Balana C, Capellades J, Pineda E, Estival A, Puig J, Domenech S . Pseudoprogression as an adverse event of glioblastoma therapy. Cancer Med. 2017; 6(12):2858-2866. PMC: 5727237. DOI: 10.1002/cam4.1242. View

Nael K, Bauer A, Hormigo A, Lemole M, Germano I, Puig J . Multiparametric MRI for Differentiation of Radiation Necrosis From Recurrent Tumor in Patients With Treated Glioblastoma. AJR Am J Roentgenol. 2017; 210(1):18-23. DOI: 10.2214/AJR.17.18003. View

Chu H, Choi S, Ryoo I, Kim S, Yeom J, Shin H . Differentiation of true progression from pseudoprogression in glioblastoma treated with radiation therapy and concomitant temozolomide: comparison study of standard and high-b-value diffusion-weighted imaging. Radiology. 2013; 269(3):831-40. DOI: 10.1148/radiol.13122024. View

Reuter M, Gerstner E, Rapalino O, Batchelor T, Rosen B, Fischl B . Impact of MRI head placement on glioma response assessment. J Neurooncol. 2014; 118(1):123-9. PMC: 4026260. DOI: 10.1007/s11060-014-1403-8. View

Galldiks N, Law I, Pope W, Arbizu J, Langen K . The use of amino acid PET and conventional MRI for monitoring of brain tumor therapy. Neuroimage Clin. 2017; 13:386-394. PMC: 5226808. DOI: 10.1016/j.nicl.2016.12.020. View

Thomsen H, Steffensen E, Larsson E . Perfusion MRI (dynamic susceptibility contrast imaging) with different measurement approaches for the evaluation of blood flow and blood volume in human gliomas. Acta Radiol. 2011; 53(1):95-101. DOI: 10.1258/ar.2011.110242. View

10.

Gzell C, Wheeler H, McCloud P, Kastelan M, Back M . Small increases in enhancement on MRI may predict survival post radiotherapy in patients with glioblastoma. J Neurooncol. 2016; 128(1):67-74. DOI: 10.1007/s11060-016-2074-4. View

11.

Zhang H, Ma L, Shu C, Wang Y, Dong L . Diagnostic accuracy of diffusion MRI with quantitative ADC measurements in differentiating glioma recurrence from radiation necrosis. J Neurol Sci. 2015; 351(1-2):65-71. DOI: 10.1016/j.jns.2015.02.038. View

12.

Bulnes S, Bilbao J, Lafuente J . Microvascular adaptive changes in experimental endogenous brain gliomas. Histol Histopathol. 2009; 24(6):693-706. DOI: 10.14670/HH-24.693. View

13.

Patterson D, Padhani A, Collins D . Technology insight: water diffusion MRI--a potential new biomarker of response to cancer therapy. Nat Clin Pract Oncol. 2008; 5(4):220-33. DOI: 10.1038/ncponc1073. View

14.

Danchaivijitr N, Waldman A, Tozer D, Benton C, Brasil Caseiras G, Tofts P . Low-grade gliomas: do changes in rCBV measurements at longitudinal perfusion-weighted MR imaging predict malignant transformation?. Radiology. 2008; 247(1):170-8. DOI: 10.1148/radiol.2471062089. View

15.

Wang S, Chen Y, Lal B, Ford E, Tryggestad E, Armour M . Evaluation of radiation necrosis and malignant glioma in rat models using diffusion tensor MR imaging. J Neurooncol. 2011; 107(1):51-60. PMC: 3268835. DOI: 10.1007/s11060-011-0719-x. View

16.

Ellingson B, Chung C, Pope W, Boxerman J, Kaufmann T . Pseudoprogression, radionecrosis, inflammation or true tumor progression? challenges associated with glioblastoma response assessment in an evolving therapeutic landscape. J Neurooncol. 2017; 134(3):495-504. PMC: 7893814. DOI: 10.1007/s11060-017-2375-2. View

17.

Sugahara T, Korogi Y, Kochi M, Ikushima I, Hirai T, Okuda T . Correlation of MR imaging-determined cerebral blood volume maps with histologic and angiographic determination of vascularity of gliomas. AJR Am J Roentgenol. 1998; 171(6):1479-86. DOI: 10.2214/ajr.171.6.9843274. View

18.

Wick W, Chinot O, Bendszus M, Mason W, Henriksson R, Saran F . Evaluation of pseudoprogression rates and tumor progression patterns in a phase III trial of bevacizumab plus radiotherapy/temozolomide for newly diagnosed glioblastoma. Neuro Oncol. 2016; 18(10):1434-41. PMC: 5035525. DOI: 10.1093/neuonc/now091. View

19.

Hu X, Wong K, Young G, Guo L, Wong S . Support vector machine multiparametric MRI identification of pseudoprogression from tumor recurrence in patients with resected glioblastoma. J Magn Reson Imaging. 2011; 33(2):296-305. PMC: 3273302. DOI: 10.1002/jmri.22432. View

20.

Server A, Kulle B, Gadmar O, Josefsen R, Kumar T, Nakstad P . Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas. Eur J Radiol. 2010; 80(2):462-70. DOI: 10.1016/j.ejrad.2010.07.017. View